Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Nitric Oxide Shown To Cause Colon Cancer

By LabMedica International staff writers
Posted on 12 Feb 2009
Scientists have long established a link between inflammation, cancer, and the compound nitric oxide, which may be produced when the immune system responds to bacterial infections, including those of the colon. More...
However, the precise nature of the relationship was unknown--until now.

Researchers from the Massachusetts Institute of Technology's (MIT; Cambridge, MA, USA) division of comparative medicine and department of biological engineering recently discovered that nitric oxide produced by inflammatory cells during bacterial infection can cause colon cells to become cancerous. This finding suggests that suppressing the compound may help prevent or treat colon cancer, the third most common form of cancer in the United States.

The researchers, led by Dr. James Fox, director of the division of comparative medicine, reported their findings in the January 19, 2008, online edition of the journal Proceedings of the [U.S.] National Academy of Sciences (PNAS).

Many years ago, it was discovered that gastrointestinal infection by Helicobacter pylori is frequently associated with cancer in humans; a related bacteria called H. hepaticus has similar effects in mice. Nitric oxide is produced during the inflammatory response to such bacterial infection, but it has been unclear whether it was damaging cells or protecting them. By studying the mice, the MIT team revealed that nitric oxide produced by different types of cells has different effects. "Nitric oxide delivered by inflammatory cells, in particular, is important in causing changes in intestinal epithelial cells, setting the stage for cancer development,” said Dr. Susan Erdman, lead research scientist in the division of comparative medicine and lead author of the PNAS article.

In mice infected with H. hepaticus, the researchers found that blocking an enzyme required to generate nitric oxide reduced colon cancer rates. More research is needed to study the exact effects of nitric oxide and develop potential clinical therapies for colon cancer, according to Dr. Erdman. "Therapies will need to be targeted to inhibit the damaging effects of nitric oxide while preserving as many of the protective elements of nitric oxide as possible,” she said.

"This study is a wonderful example of the value and final product that results from an interdisciplinary team effort,” concluded Dr. Fox.

Related Links:

Massachusetts Institute of Technology



New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Hematology Analyzer
Medonic M32B
Hemodynamic System Monitor
OptoMonitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.